Yet another New York cannabis lawsuit 🗽

Plus, Texas moves to ban hemp-derived THC

We have a timeline for the rescheduling hearings 👀

Plus, arguments heard in federal cannabis case

Is SAFER Banking doomed?

Plus, Trump’s DEA nominee withdraws

The DEA’s hearing on cannabis rescheduling kicks off 👀

Plus, Green Wednesday sales boost

Trump’s new DEA pick

Plus, 280E taxes, and more

Digging into the rescheduling hearing statements 🌿

Plus, it’s Green Wednesday!

A $3.4 billion deal goes to zero

Plus, Minnesota license lottery delayed

Reading the Administration's cannabis tea leaves

Plus, does F1 have a problem with cannabis

The cannabis industry continues to watch DC

Plus, the latest from the industry lawsuit against the Feds

A groundbreaking lawsuit challenges federal oversight of state cannabis markets: Insights with Josh Schiller

The rescheduling hearing is getting a bit messy 👀

Plus, Distru raises $6 million from Poseidon

Inside New York’s cannabis rollout: Outgoing chief equity officer reveals successes and setbacks

The outgoing chief equity officer of New York’s cannabis program shares what went right — and wrong — during his rocky tenure